✦ LIBER ✦

Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy

✍ Scribed by Antoinette R. Tan; Sandra M. Swain

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotective action of flavopiridol,

✍ Elvira G Jorda; Ester Verdaguer; Anna M Canudas; Andrés Jiménez; Alejandra Bruna 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Phase I Trial of the Cyclin-Dependent Ki

✍ Nahta, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Flavopiridol, a cyclin dependent kinase

✍ Mariko Mihara; Satoru Shintani; Koh-ichi Nakashiro; Hiroyuki Hamakawa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Phase II trial of flavopiridol, a cyclin

✍ Susan Burdette-Radoux; Richard G. Tozer; Reinhard C. Lohmann; Ian Quirt; D. Scot 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 70 KB

Multiple Roles of Cyclin-Dependent Kinas

✍ Roberts, P. J.; Bisi, J. E.; Strum, J. C.; Combest, A. J.; Darr, D. B.; Usary, J 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 803 KB

Metabolism of the anticancer drug flavop

✍ Walter Jäger; Bettina Zembsch; Peter Wolschann; Ernst Pittenauer; Adrian M. send 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 825 KB